FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1981108103> ?p ?o ?g. }

• W1981108103 endingPage "H12" @default.
• W1981108103 startingPage "H10" @default.
• W1981108103 abstract "EDITORIAL FOCUSExtracellular SOD and aged blood vesselsTohru FukaiTohru FukaiPublished Online:01 Jul 2009https://doi.org/10.1152/ajpheart.00425.2009This is the final version - click for previous versionMoreSectionsPDF (126 KB)Download PDF ToolsExport citationAdd to favoritesGet permissionsTrack citations ShareShare onFacebookTwitterLinkedInEmailWeChat aging, which is closely linked to oxidative stress, is an independent risk factor for various cardiovascular diseases (1). The role of reactive oxygen species (ROS) such as superoxide (O2•−) in the aging process was initially proposed as the “free radical theory” by Harman in the 1950s (12), whereby ROS attack cellular molecules and cause the functional decline of organ systems, which eventually leads to death. Aging is dependent on mitochondrial dysfunction, cellular senescence, inflammation, and vascular dysfunction, which are associated with ROS (Fig. 1) (16). Underlying mechanisms remain unclear. In normal blood vessels, nitric oxide (NO) is released from the endothelium and diffuses into smooth muscle to produce vasorelaxation. In aged vessels, O2•− levels are increased by mitochondrial dysfunction or NADPH oxidase activation and negatively regulated (reduced) by antioxidant enzymes such as Mn-SOD (SOD-2) and cytosolic Cu,Zn-SOD (SOD-1) (1, 16). NO reacts with O2•− to form peroxynitrite (ONOO−), which can induce protein modifications and DNA damage (20). Reduction of endothelium-derived NO contributes to vasoconstriction and inflammation. Thus a decrease in NO bioavailability as a result of excess O2•− formation is a major cause of endothelial dysfunction in aging.Fig. 1.Role of extracellular superoxide dismutase (ecSOD) in endothelial function during aging. A causative role of reactive oxygen species (ROS) in the aging process has been referred to as the free radical theory of aging (12). In particular, senescence, mitochondrial dysfunction, and inflammation have been proposed to be linked to aging via ROS (16). In aged ecSOD−/− mice, endothelium-dependent vasorelaxation is markedly impaired. During aging, decreased expression of ecSOD leads to an increase in extracellular O2•−, resulting in oxidative inactivation of endothelial nitric oxide (NO) synthase (eNOS)-derived NO and peroxynitrite (ONOO−) formation, which in turn contribute to endothelial dysfunction. Given that eNOS-derived NO increases ecSOD transcription, the aging-induced decrease in eNOS expression may result in a decrease in ecSOD. This further increases extracellular O2•− levels and, thus, promoting impaired endothelial function.Download figureDownload PowerPointThe extracellular form of Cu,Zn-SOD (ecSOD, SOD-3) is the major SOD in the vascular extracellular space. It protects against inactivation of NO released from the endothelium by O2•− during diffusion to smooth muscle (19), thereby preserving endothelial function. In studies using ecSOD-deficient mice, ecSOD has been shown to play an important role in various oxidative stress-dependent pathophysiologies, including hypertension, ischemia-reperfusion injury, and lung injury (7, 8, 23). Several lines of evidence suggest a role for ecSOD in aging. The R213G polymorphism in the ecSOD gene has been linked to an increase in cardiovascular risk (15) that is not revealed until 70 yr of age in humans. Plasma levels of ecSOD decrease with aging (6), and gene transfer of ecSOD improves endothelial function in old rats (2). However, it remains unknown whether ecSOD expression or activity in blood vessels is regulated by aging and whether endogenous ecSOD is involved in regulation of vascular function during aging.In this issue, using aged (old) and younger (adult) ecSOD−/− mice, Lund et al. (16a) provide the first evidence in aged (old) and old (adult) ecSOD−/− mice that endogenous ecSOD plays an essential role in protection against O2•−-mediated endothelial dysfunction during aging. They showed that acetylcholine-induced endothelium-dependent relaxation of the aorta from old (29 mo old) and adult (11 mo old) ecSOD−/− mice is significantly impaired compared with that from wild-type mice at each age, whereas sodium nitroprusside-induced relaxation is not altered. Moreover, the extent of endothelial dysfunction is much greater in aged ecSOD−/− than younger ecSOD−/− mice and is rescued by infusion of the SOD mimetic tempol. Impaired relaxation of arteries in response to acetylcholine with increasing age is consistent with previous studies in rats (2) and is presumably due to elevated levels of O2•− in aged arteries (2). Although Lund et al. did not measure O2•− levels in aged ecSOD−/− mice, tempol-induced restoration of relaxation to acetylcholine strongly supports the possibility that O2•− is increased in the aorta of these mice. Their data also suggest that impaired endothelial function in aged ecSOD−/− mice might be due to reduced bioavailability of NO, rather than impaired smooth muscle function. ecSOD expression is also significantly decreased in the aorta from old mice compared with young mice, and the correlation between endothelial function and ecSOD expression is much steeper in aged mice than younger mice. These findings suggest a greater protective effect of ecSOD against endothelial dysfunction in aged mice. This may be due to higher vascular O2•− levels in old mice than in younger animals (2). Consistent with this idea, Brown et al. (2) demonstrated that gene transfer of ecSOD in old rats reduces O2•− to the levels observed in young rats and restores vascular function without significant effects on young animals. These findings indicate that ecSOD more effectively protects against endothelial dysfunction in aged animals, which would have higher extracellular O2•− levels than younger animals.Consistent with the results from ecSOD−/− mice, previous reports show that endothelium-dependent vasorelaxation is markedly impaired in old Cu,Zn-SOD+/− and Mn-SOD+/− mice because of enhanced O2•− production compared with young mice (3, 5). One of the underlying mechanisms has been explained by activation of poly(ADP-ribose) polymerase via oxidative DNA damage (21), because poly(ADP-ribose) polymerase inhibitor improves endothelial function in old Cu,Zn-SOD+/− mice (5). Importantly, this response is not observed in Mn-SOD+/− mice (3). Although Lund et al. (16a) show no effects on vessel contraction induced by PGF2α or serotonin in aged ecSOD−/− mice, vasoconstriction is enhanced in aged Cu,Zn-SOD+/− and Mn-SOD+/− mice. Thus each isoform of SOD, expressed in a different location of the vessel wall, seems to play an important role in protecting vascular function during aging through distinct mechanisms.Lund et al. (16a) also reported that mRNA levels of ecSOD, but not Cu,Zn-SOD or Mn-SOD, are significantly reduced in aged (old) mice compared with younger (adult) mice. This finding is consistent with a previous report of no compensatory upregulation of Cu,Zn-SOD or Mn-SOD in ecSOD−/− mice (11, 14). Mechanisms for selective reduction of ecSOD with aging are not clear. Reduced levels of ecSOD have been reported in plasma of older patients (6). Because endothelial NO synthase (eNOS) is a positive regulator for ecSOD expression (9, 18) and the eNOS level tended to be decreased in aged mice in the study of Lund et al. (16a), reduced eNOS may also contribute to decreased ecSOD mRNA expression. Lu et al. (17) reported a decrease in cardiac Cu,Zn-SOD activity but no change in Cu,Zn-SOD protein levels in ecSOD−/− mice challenged with pressure overload. This might be caused by inactivation of Cu,Zn-SOD by ONOO−, which is formed by reaction of NO with O2•− due to ecSOD deficiency (10). It is tempting to speculate that a similar phenomenon may be observed in aged ecSOD−/− mice. Thus, not only mRNA, but also protein level and activity of Cu,Zn-SOD or Mn-SOD, in aged ecSOD−/− mice, as well as ecSOD protein and activity in aged mice, should be measured in a future study.The findings of Lund et al. (16a) strongly support a critical role of ecSOD as a regulator of NO bioavailability and endothelial function during aging (Fig. 1). As they pointed out, their findings will have potential clinical implications in relation to a gene polymorphism (R213G) found in humans in the heparin-binding site of ecSOD (15). This gene variant impairs binding of ecSOD to the vessel wall and, thus, impairs protection of vessels from the increased levels of O2•− in the extracellular space (4). The findings of Lund et al. may explain why the risk of ischemic heart disease in subjects with ecSODR213G is confined to individuals >70 yr old (15). There are many unanswered questions. It has been shown that the level of ecSOD in cells is positively associated with the length of telomeres in human fibroblast lines (24). Is this relevant to the findings of Lund et al.? ecSOD activity and expression are regulated at transcriptional and posttranslational levels (25). For example, full activation of ecSOD requires copper carrier protein in order to obtain its catalytic copper (13, 22). Does this protein play a role in regulation of endothelial function during aging through control of ecSOD activity? Addressing these questions will be essential to an understanding of the mechanism of oxidative stress-dependent cardiovascular diseases and aging, in which extracellular O2•− may play an essential role.GRANTSThis work was supported by National Heart, Lung, and Blood Institute Grant 5R01 HL-070187-08.I thank Dr. Masuko Ushio-Fukai for critical review of the manuscript and helpful comments.REFERENCES1 Brandes RP, Fleming I, Busse R. Endothelial aging. Cardiovasc Res 66: 286–294, 2005.Crossref | PubMed | ISI | Google Scholar2 Brown KA, Chu Y, Lund DD, Heistad DD, Faraci FM. Gene transfer of extracellular superoxide dismutase protects against vascular dysfunction with aging. Am J Physiol Heart Circ Physiol 290: H2600–H2605, 2006.Link | ISI | Google Scholar3 Brown KA, Didion SP, Andresen JJ, Faraci FM. Effect of aging, MnSOD deficiency, and genetic background on endothelial function: evidence for MnSOD haploinsufficiency. Arterioscler Thromb Vasc Biol 27: 1941–1946, 2007.Crossref | PubMed | ISI | Google Scholar4 Chu Y, Alwahdani A, Iida S, Lund DD, Faraci FM, Heistad DD. Vascular effects of the human extracellular superoxide dismutase R213G variant. Circulation 112: 1047–1053, 2005.Crossref | PubMed | ISI | Google Scholar5 Didion SP, Kinzenbaw DA, Schrader LI, Faraci FM. Heterozygous CuZn superoxide dismutase deficiency produces a vascular phenotype with aging. Hypertension 48: 1072–1079, 2006.Crossref | PubMed | ISI | Google Scholar6 Di Massimo C, Scarpelli P, Di Lorenzo N, Caimi G, di Orio F, Ciancarelli MG. Impaired plasma nitric oxide availability and extracellular superoxide dismutase activity in healthy humans with advancing age. Life Sci 78: 1163–1167, 2006.Crossref | PubMed | ISI | Google Scholar7 Fattman CL, Schaefer LM, Oury TD. Extracellular superoxide dismutase in biology and medicine. Free Radic Biol Med 35: 236–256, 2003.Crossref | PubMed | ISI | Google Scholar8 Fukai T, Folz RJ, Landmesser U, Harrison DG. Extracellular superoxide dismutase and cardiovascular disease. Cardiovasc Res 55: 239–249, 2002.Crossref | PubMed | ISI | Google Scholar9 Fukai T, Siegfried MR, Ushio-Fukai M, Cheng Y, Kojda G, Harrison DG. Regulation of the vascular extracellular superoxide dismutase by nitric oxide and exercise training. J Clin Invest 105: 1631–1639, 2000.Crossref | PubMed | ISI | Google Scholar10 Gongora MC, Harrison DG. Sad heart from no SOD. Hypertension 51: 28–30, 2008.Crossref | PubMed | ISI | Google Scholar11 Gongora MC, Qin Z, Laude K, Kim HW, McCann L, Folz JR, Dikalov S, Fukai T, Harrison DG. Role of extracellular superoxide dismutase in hypertension. Hypertension 48: 473–481, 2006.Crossref | PubMed | ISI | Google Scholar12 Harman D. Aging: a theory based on free radical and radiation chemistry. J Gerontol 11: 298–300, 1956.Crossref | PubMed | Google Scholar13 Itoh S, Ozumi K, Kim HW, Nakagawa O, McKinney RD, Folz RJ, Zelko IN, Ushio-Fukai M, Fukai T. Novel mechanism for regulation of extracellular SOD transcription and activity by copper: role of antioxidant-1. Free Radic Biol Med 46: 95–104, 2009.Crossref | PubMed | ISI | Google Scholar14 Jung O, Marklund SL, Geiger H, Pedrazzini T, Busse R, Brandes RP. Extracellular superoxide dismutase is a major determinant of nitric oxide bioavailability: in vivo and ex vivo evidence from ecSOD-deficient mice. Circ Res 93: 622–629, 2003.Crossref | PubMed | ISI | Google Scholar15 Juul K, Tybjaerg-Hansen A, Marklund S, Heegaard NH, Steffensen R, Sillesen H, Jensen G, Nordestgaard BG. Genetically reduced antioxidative protection and increased ischemic heart disease risk: the Copenhagen City Heart Study. Circulation 109: 59–65, 2004.Crossref | PubMed | ISI | Google Scholar16 Kregel KC, Zhang HJ. An integrated view of oxidative stress in aging: basic mechanisms, functional effects, and pathological considerations. Am J Physiol Regul Integr Comp Physiol 292: R18–R36, 2007.Link | ISI | Google Scholar16a Lund DD, Chu Y, Miller JD, Heistad DD. Protective effect of extracellular superoxide dismutase on endothelial function during aging. Am J Physiol Heart Circ Physiol. doi:10.1152/ajpheart.01342.2008.Link | ISI | Google Scholar17 Lu Z, Xu X, Hu X, Zhu G, Zhang P, van Deel ED, French JP, Fassett JT, Oury TD, Bache RJ, Chen Y. Extracellular superoxide dismutase deficiency exacerbates pressure overload-induced left ventricular hypertrophy and dysfunction. Hypertension 51: 19–25, 2008.Crossref | PubMed | ISI | Google Scholar18 Oppermann M, Balz V, Adams V, Dao VT, Bas M, Suvorava T, Kojda G.Pharmacologic induction of vascular extracellular superoxide dismutase expression in-vivo. J Cell Mol Med. In press.Google Scholar19 Oury TD, Day BJ, Crapo JD. Extracellular superoxide dismutase: a regulator of nitric oxide bioavailability. Lab Invest 75: 617–636, 1996.PubMed | ISI | Google Scholar20 Pacher P, Beckman JS, Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev 87: 315–424, 2007.Link | ISI | Google Scholar21 Pacher P, Szabo C. Role of the peroxynitrite-poly(ADP-ribose) polymerase pathway in human disease. Am J Pathol 173: 2–13, 2008.Crossref | PubMed | ISI | Google Scholar22 Qin Z, Gongora MC, Ozumi K, Itoh S, Akram K, Ushio-Fukai M, Harrison DG, Fukai T. Role of Menkes ATPase in angiotensin II-induced hypertension: a key modulator for extracellular superoxide dismutase function. Hypertension 52: 945–951, 2008.Crossref | PubMed | ISI | Google Scholar23 Qin Z, Reszka KJ, Fukai T, Weintraub NL. Extracellular superoxide dismutase (ecSOD) in vascular biology: an update on exogenous gene transfer and endogenous regulators of ecSOD. Transl Res 151: 68–78, 2008.Crossref | PubMed | ISI | Google Scholar24 Serra V, von Zglinicki T, Lorenz M, Saretzki G. Extracellular superoxide dismutase is a major antioxidant in human fibroblasts and slows telomere shortening. J Biol Chem 278: 6824–6830, 2003.Crossref | PubMed | ISI | Google Scholar25 Zelko IN, Mariani TJ, Folz RJ. Superoxide dismutase multigene family: a comparison of the CuZn-SOD (SOD1), Mn-SOD (SOD2), and EC-SOD (SOD3) gene structures, evolution, and expression. Free Radic Biol Med 33: 337–349, 2002.Crossref | PubMed | ISI | Google ScholarAUTHOR NOTESAddress for reprint requests and other correspondence: T. Fukai, Depts. of Medicine (Section of Cardiology) and Pharmacology, Center for Cardiovascular Research, Univ. of Illinois at Chicago, 835 S. Wolcott, M/C868, E403MSB, Chicago, IL 60612 (e-mail: [email protected]) Download PDF Previous Back to Top Next FiguresReferencesRelatedInformationCited ByAntioxidant Categories and Mode of Action6 November 2019The role of polysaccharide peptide of Ganoderma lucidum as a potent protective vascular endothelial cell, anti inflammation, and antioxidant in STEMI and NSTEMI patientsFarnesoid X Receptor Antagonizes JNK Signaling Pathway in Liver Carcinogenesis by Activating SOD3Molecular Endocrinology, Vol. 29, No. 2Vascular Endothelial Function2 February 2015Vascular Endothelial Function31 July 2014Transcriptional and phenotypic changes in aorta and aortic valve with aging and MnSOD deficiency in miceCarolyn M. Roos, Michael Hagler, Bin Zhang, Elise A. Oehler, Arman Arghami, and Jordan D. Miller15 November 2013 | American Journal of Physiology-Heart and Circulatory Physiology, Vol. 305, No. 10Endothelial Aging Associated with Oxidative Stress Can Be Modulated by a Healthy Mediterranean Diet24 April 2013 | International Journal of Molecular Sciences, Vol. 14, No. 5Biological Activities and Cell Proliferation effects of Red Ginseng Ethanol ExtractsJournal of Pharmacopuncture, Vol. 14, No. 3The effects of aging on pulmonary oxidative damage, protein nitration, and extracellular superoxide dismutase down-regulation during systemic inflammationFree Radical Biology and Medicine, Vol. 50, No. 2Pathophysiological Roles of NADPH Oxidase/Nox Family Proteins in the Vascular System - Review and Perspective -Circulation Journal, Vol. 75, No. 8Endothelial dysfunction and aging: An updateAgeing Research Reviews, Vol. 9, No. 2 More from this issue > Volume 297Issue 1July 2009Pages H10-H12 Copyright & PermissionsCopyright © 2009 the American Physiological Societyhttps://doi.org/10.1152/ajpheart.00425.2009PubMed19465548History Published online 1 July 2009 Published in print 1 July 2009 Metrics" @default.
• W1981108103 created "2016-06-24" @default.
• W1981108103 creator A5085309946 @default.
• W1981108103 date "2009-07-01" @default.
• W1981108103 modified "2023-09-27" @default.
• W1981108103 title "Extracellular SOD and aged blood vessels" @default.
• W1981108103 cites W1970382485 @default.
• W1981108103 cites W2012584055 @default.
• W1981108103 cites W2026433593 @default.
• W1981108103 cites W2057602082 @default.
• W1981108103 cites W2059311419 @default.
• W1981108103 cites W2062502922 @default.
• W1981108103 cites W2067232891 @default.
• W1981108103 cites W2103709392 @default.
• W1981108103 cites W2103900156 @default.
• W1981108103 cites W2104109524 @default.
• W1981108103 cites W2118711119 @default.
• W1981108103 cites W2121095437 @default.
• W1981108103 cites W2122386753 @default.
• W1981108103 cites W2127738631 @default.
• W1981108103 cites W2128014750 @default.
• W1981108103 cites W2129529988 @default.
• W1981108103 cites W2133771754 @default.
• W1981108103 cites W2137861969 @default.
• W1981108103 cites W2144475885 @default.
• W1981108103 cites W2145319267 @default.
• W1981108103 cites W2171170747 @default.
• W1981108103 cites W2315512556 @default.
• W1981108103 cites W2912908815 @default.
• W1981108103 cites W4256530495 @default.
• W1981108103 doi "https://doi.org/10.1152/ajpheart.00425.2009" @default.
• W1981108103 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5504446" @default.
• W1981108103 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19465548" @default.
• W1981108103 hasPublicationYear "2009" @default.
• W1981108103 type Work @default.
• W1981108103 sameAs 1981108103 @default.
• W1981108103 citedByCount "14" @default.
• W1981108103 countsByYear W19811081032012 @default.
• W1981108103 countsByYear W19811081032013 @default.
• W1981108103 countsByYear W19811081032014 @default.
• W1981108103 countsByYear W19811081032015 @default.
• W1981108103 countsByYear W19811081032019 @default.
• W1981108103 crossrefType "journal-article" @default.
• W1981108103 hasAuthorship W1981108103A5085309946 @default.
• W1981108103 hasBestOaLocation W19811081032 @default.
• W1981108103 hasConcept C28406088 @default.
• W1981108103 hasConcept C86803240 @default.
• W1981108103 hasConcept C95444343 @default.
• W1981108103 hasConceptScore W1981108103C28406088 @default.
• W1981108103 hasConceptScore W1981108103C86803240 @default.
• W1981108103 hasConceptScore W1981108103C95444343 @default.
• W1981108103 hasIssue "1" @default.
• W1981108103 hasLocation W19811081031 @default.
• W1981108103 hasLocation W19811081032 @default.
• W1981108103 hasLocation W19811081033 @default.
• W1981108103 hasLocation W19811081034 @default.
• W1981108103 hasOpenAccess W1981108103 @default.
• W1981108103 hasPrimaryLocation W19811081031 @default.
• W1981108103 hasRelatedWork W1540690193 @default.
• W1981108103 hasRelatedWork W1577673639 @default.
• W1981108103 hasRelatedWork W160183570 @default.
• W1981108103 hasRelatedWork W1970082812 @default.
• W1981108103 hasRelatedWork W1987701863 @default.
• W1981108103 hasRelatedWork W2072644808 @default.
• W1981108103 hasRelatedWork W2797952716 @default.
• W1981108103 hasRelatedWork W2917685500 @default.
• W1981108103 hasRelatedWork W3094530946 @default.
• W1981108103 hasRelatedWork W4206349716 @default.
• W1981108103 hasVolume "297" @default.
• W1981108103 isParatext "false" @default.
• W1981108103 isRetracted "false" @default.
• W1981108103 magId "1981108103" @default.
• W1981108103 workType "article" @default.